Title |
Sumatriptan plus naproxen for acute migraine attacks in adults
|
---|---|
Published by |
John Wiley & Sons, Ltd, October 2013
|
DOI | 10.1002/14651858.cd008541.pub2 |
Pubmed ID | |
Authors |
Law, Simon, Derry, Sheena, Moore, R Andrew |
Abstract |
Migraine is a common disabling condition and a burden for the individual, health services, and society. Effective abortive treatments include the triptan and non-steroidal anti-inflammatory classes of drugs. These drugs have different mechanisms of action and combining them may provide better relief. Sumatriptan plus naproxen is now available in combination form for the acute treatment of migraine. |
Twitter Demographics
The data shown below were collected from the profiles of 24 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 6 | 25% |
United States | 6 | 25% |
Spain | 3 | 13% |
Colombia | 2 | 8% |
Australia | 1 | 4% |
Bahrain | 1 | 4% |
Germany | 1 | 4% |
Unknown | 4 | 17% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 15 | 63% |
Practitioners (doctors, other healthcare professionals) | 6 | 25% |
Scientists | 2 | 8% |
Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Colombia | 1 | 1% |
Brazil | 1 | 1% |
United Kingdom | 1 | 1% |
Spain | 1 | 1% |
United States | 1 | 1% |
Unknown | 70 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 12 | 16% |
Researcher | 10 | 13% |
Student > Bachelor | 10 | 13% |
Student > Master | 9 | 12% |
Other | 7 | 9% |
Other | 13 | 17% |
Unknown | 14 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 33 | 44% |
Psychology | 5 | 7% |
Neuroscience | 4 | 5% |
Nursing and Health Professions | 3 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
Other | 11 | 15% |
Unknown | 16 | 21% |